Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegeneration
Open Access
- 19 December 2023
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1826, 148733
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (F30-HL149252, R01-NS100529, T32-GM007365, U24-CA210990, U54-AG075932)
This publication has 33 references indexed in Scilit:
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- The Subread aligner: fast, accurate and scalable read mapping by seed-and-voteNucleic Acids Research, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Shaping the role of mitochondria in the pathogenesis of Huntington's diseaseThe EMBO Journal, 2012
- A guide to analysis of mouse energy metabolismNature Methods, 2011
- Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's diseaseNeurobiology of Disease, 2011
- Selective deficits in the expression of striatal‐enriched mRNAs in Huntington's diseaseJournal of Neurochemistry, 2006
- The use of the R6 transgenic mouse models of Huntington’s disease in attempts to develop novel therapeutic strategiesNeuroRX, 2005
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996